Abstract: A flux-concentrating rotor structure is disclosed and includes an iron core and plural magnet components. The iron core is formed by stacking plural silicon steel sheets and includes plural magnet-receiving slots arranged along a circumferential direction. Each magnet-receiving slot has a T-shaped section. Each two adjacent magnet-receiving slots have a radial bridge, whereby each silicon steel sheet is integrally formed. The magnet components are arranged in the iron core, and correspondingly received within the magnet-receiving slots. Each magnet component includes two radial magnets and one tangential magnet. The two radial magnets are located on both sides of the tangential magnet along the circumferential direction and in contact with the tangential magnet. The two radial magnets are magnetized along the radial direction respectively and have opposite magnetizing directions. The tangential magnet is magnetized along the tangential direction.

Abstract: A novel fusion protein to overcome the current difficulties related to application of monoclonal antibodies in disease treatment and in other fields, particularly those requiring ADCC, e.g. for depletion of tumor cells, virally-infected cells, or immune-modulating cells, etc. One example of the fusion protein is an extracellular domain of a high-affinity variant of human CD 16 A fused to an anti-CD3 antibody or its antigen-binding fragment thereof that specifically binds to an epitope on human CD3 or a fragment thereof.

Abstract: A novel fusion protein to overcome the current difficulties related to application of monoclonal antibodies in disease treatment and in other fields, particularly those requiring ADCC, e.g. for depletion of tumor cells, virally-infected cells, or immune-modulating cells, etc. One example of the fusion protein is an extracellular domain of a high-affinity variant of human CD 16 A fused to an anti-CD3 antibody or its antigen-binding fragment thereof that specifically binds to an epitope on human CD3 or a fragment thereof.

Abstract: Provided are methods for treatment of cancer by administering to an individual who has a cancer that includes cancer cells that have an LKBI mutation an anti-CD38 agent, an inhibitor of EP300, or a combination thereof. Methods are also provided for treating an individual who has a cancer that includes cancer cells that do not have an LKBI mutation a Salt-Inducible Kinase (SIK) inhibitor and an anti-CD38 agent. The SIK inhibitors sensitizes the cancer cells that do not have the LKBI mutation to the anti-CD38 agent.

Abstract: A stator structure of a vehicle motor includes a stator core assembly and a plurality of coil assemblies composed of flat wires. The stator core assembly includes an annular portion and a plurality of tooth portions. The tooth portions extend from the annular portion in a radial direction toward a center of the stator core assembly. Each coil assembly is configured around a corresponding tooth portion. Each coil assembly includes a first flat wire and a plurality of second flat wires that are electrically connected in parallel. The first flat wire is radially stacked and wound around the corresponding tooth portion. The second flat wires are arranged radially adjacent to the first flat wire and are electrically connected in series to the first flat wire. The second flat wires are alternately stacked and radially wound around the corresponding tooth portion.

Abstract: Crystalline 4-((L-valyl)oxy)butanoic acid, methods of preparing crystalline 4-((L-valyl)oxy)butanoic acid, pharmaceutical compositions of crystalline 4-((L-valyl)oxy)butanoic acid, and methods of treatment using crystalline 4-((L-valyl)oxy)butanoic acid are disclosed.

Abstract: A transistor includes a first semiconductor layer, a second semiconductor layer, a semiconductor nanosheet, a gate electrode and source and drain electrodes. The semiconductor nanosheet is physically connected to the first semiconductor layer and the second semiconductor layer. The gate electrode wraps around the semiconductor nanosheet. The source and drain electrodes are disposed at opposite sides of the gate electrode. The first semiconductor layer surrounds the source electrode, the second semiconductor layer surrounds the drain electrode, and the semiconductor nanosheet is disposed between the source and drain electrodes.

Abstract: A stator structure of a vehicle motor includes a stator core assembly and a plurality of coil assemblies composed of flat wires. The stator core assembly includes an annular portion and a plurality of tooth portions. The tooth portions extend from the annular portion in a radial direction toward a center of the stator core assembly. Each coil assembly is configured around a corresponding tooth portion. Each coil assembly includes a first flat wire and a plurality of second flat wires that are electrically connected in parallel. The first flat wire is radially stacked and wound around the corresponding tooth portion. The second flat wires are arranged radially adjacent to the first flat wire and are electrically connected in series to the first flat wire. The second flat wires are alternately stacked and radially wound around the corresponding tooth portion.

Abstract: A novel fusion protein to overcome the current difficulties related to application of monoclonal antibodies in disease treatment and in other fields, particularly those requiring ADCC, e.g. for depletion of tumor cells, virally-infected cells, or immune-modulating cells, etc. One example of the fusion protein is an extracellular domain of a high-affinity variant of human CD 16 A fused to an anti-CD3 antibody or its antigen-binding fragment thereof that specifically binds to an epitope on human CD3 or a fragment thereof.

Abstract: The disclosure provides an optical device including a diffusion layer, a light-emitting device, and a first photoluminescent film. The diffusion layer is disposed opposite to the light-emitting device, and the light-emitting device includes a plurality of light-emitting units. The first photoluminescent film is between the diffusion layer and the light-emitting device. A first distance between the first photoluminescent film and the diffusion layer is greater than a second distance between the first photoluminescent film and one of the plurality of light-emitting units. The optical device of the disclosure may improve brightness efficiency.

Abstract: Provided is a method for preparing synthetic cannabidiol, including hydrolysis-decarboxylation of a compound represented by formula (II) in a solvent-free state under atmospheric pressure. The method further includes preparation of the compound represented by formula (II). The method provides a safe, economical, environmentally friendly and scalable method for synthetic preparation of cannabidiol.

Abstract: Combinations including a bispecific T cell activating antigen binding molecule and effector memory ?9?2 T cells. Also methods of using the combinations in treating diseases such as cancers and infectious diseases.

Abstract: A gas sensing device comprises a housing, a cover, and a gas sensing module. The housing has an accommodating space. The cover is disposed on the housing. The cover has a top surface, a bottom surface, and a gas passage. The bottom surface faces the accommodating space. The gas passage is communicated with the accommodating space. The gas passage has a first opening and a second opening. The first opening is located on the top surface. The second opening is located on the bottom surface. The area of the first opening is larger than the area of the second opening. A gas sensing system comprises two aforementioned gas sensing devices, and one of the gas sensing devices is provided with a filter module.

Abstract: A display device is provided. The display device includes a display panel and a backlight module, the backlight module is corresponding disposed to the display panel. The backlight module emits a backlight having a backlight spectrum. The backlight spectrum includes a first waveband and a second waveband. The first waveband is within a range of 380 nm to 480 nm, and has a first integrated light intensity I(B). The second waveband is within a range of 481 nm to 600 nm, and has a sub-waveband within a range of 550 nm to 600 nm. The sub-waveband has a integrated light intensity I(G?), and a ratio of the integrated light intensity to the first integrated light intensity (I(G?)/I(B)) is within a range of 5% to 35%.

Abstract: A voice emitting device of a speaker is provided. The magnetic vibration element is a larger diameter and thus has a greater driving force. In use, if a greater voice is needed, the structure provided may achieve the effect without operation at full power. Because even the voice emitting device is not worked in full power, the sound quality is good. Furthermore, because the magnetic vibration element of the voice emitting device is larger, a longer impact length is provided. Therefore the response in a low frequency is good and thus the sound quality in lower frequency is not affected.

Abstract: A voice emitting device of a speaker is provided. The magnetic vibration element is a larger diameter and thus has a greater driving force. In use, if a greater voice is needed, the structure provided may achieve the effect without operation at full power. Because even the voice emitting device is not worked in full power, the sound quality is good. Furthermore, because the magnetic vibration element of the voice emitting device is larger, a longer impact length is provided. Therefore the response in a low frequency is good and thus the sound quality in lower frequency is not affected.

Abstract: An antimicrobial composite material and a method for fabricating the same are provided. The antimicrobial composite material includes a porous material, a chelating agent, and a multivalent metal ion. The chelating agent is chemically bonded to the porous material, and the multivalent metal ion is chemically bonded to the chelating agent.

Abstract: A method for enhancing differentiation of dopaminergic (DA) neurons is provided. The method of the present invention includes culturing precursor cells; administering urocortin to the precursor cells; and differentiating the precursor cells into the DA neurons.